GW873140 to Treat HIV-1 Infected Adults

NCT00076284 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: GW873140

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)